|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.190 SEK | -0.45% |
|
-7.20% | +15.26% |
| 03:10am | Enzymatica CFO Holger Lembrér buys shares for 110,000 kronor | FW |
| 07-16 | Enzymatica AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 55.4M | - | - | - | - | - |
| 1,051B | |||||
| 609B | |||||
| 450B | |||||
| 330B | |||||
| 284B |
- Stock Market
- Stocks
- ENZY Stock
- Charts Enzymatica AB
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
